|
Originally published In Press as doi:10.1074/jbc.M412427200 on February 14, 2005
J. Biol. Chem., Vol. 280, Issue 17, 17286-17293, April 29, 2005
Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement
ROLE OF SPHINGOSINE 1-PHOSPHATE RECEPTOR TRANSACTIVATION*
James H. Finigan,
Steven M. Dudek,
Patrick A. Singleton,
Eddie T. Chiang,
Jeffrey R. Jacobson,
Sara M. Camp,
Shiu Q. Ye , and
Joe G. N. Garcia
From the
Center for Translational Respiratory Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland 21224
Increased endothelial cell (EC) permeability is central to the pathophysiology of inflammatory syndromes such as sepsis and acute lung injury (ALI). Activated protein C (APC), a serine protease critically involved in the regulation of coagulation and inflammatory processes, improves sepsis survival through an unknown mechanism. We hypothesized a direct effect of APC to both prevent increased EC permeability and to restore vascular integrity after edemagenic agonists. We measured changes in transendothelial electrical resistance (TER) and observed that APC produced concentration-dependent attenuation of TER reductions evoked by thrombin. We next explored known EC barrier-protective signaling pathways and observed dose-dependent APC-mediated increases in cortical myosin light chain (MLC) phosphorylation in concert with cortically distributed actin polymerization, findings highly suggestive of Rac GTPase involvement. We next determined that APC directly increases Rac1 activity, with inhibition of Rac1 activity significantly attenuating APC-mediated barrier protection to thrombin challenge. Finally, as these signaling events were similar to those evoked by the potent EC barrier-enhancing agonist, sphingosine 1-phosphate (S1P), we explored potential cross-talk between endothelial protein C receptor (EPCR) and S1P1, the receptors for APC and S1P, respectively. EPCR-blocking antibody (RCR-252) significantly attenuated both APC-mediated barrier protection and increased MLC phosphorylation. We next observed rapid, EPCR and PI 3-kinase-dependent, APC-mediated phosphorylation of S1P1 on threonine residues consistent with S1P1 receptor activation. Co-immunoprecipitation studies demonstrate an interaction between EPCR and S1P1 upon APC treatment. Targeted silencing of S1P1 expression using siRNA significantly reduced APC-mediated barrier protection against thrombin. These data suggest that novel EPCR ligation and S1P1 transactivation results in EC cytoskeletal rearrangement and barrier protection, components potentially critical to the improved survival of APC-treated patients with severe sepsis.
Received for publication, November 3, 2004
, and in revised form, January 24, 2005.
* This work was supported by Grant HL 58064 from the NHLBI, National Institutes of Health, the Johns Hopkins Eudowood fellowship, and the Dr. David Marine Endowment. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Recipient of Grant F1K-US-V010 from Eli Lilly and Co.
To whom correspondence should be addressed: Dept. of Medicine, University of Chicago Pritzker School of Medicine, 5841 S. Maryland Ave., W604, Chicago, IL 60637. Tel.: 773-702-1051; Fax: 773-702-4427; E-mail: jgarcia{at}medicine.bsd.uchicago.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. O. Mosnier, A. Zampolli, E. J. Kerschen, R. A. Schuepbach, Y. Banerjee, J. A. Fernandez, X. V. Yang, M. Riewald, H. Weiler, Z. M. Ruggeri, et al.
Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant
Blood,
June 4, 2009;
113(23):
5970 - 5978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Finigan, A. Boueiz, E. Wilkinson, R. Damico, J. Skirball, H. H. Pae, M. Damarla, E. Hasan, D. B. Pearse, S. P. Reddy, et al.
Activated protein C protects against ventilator-induced pulmonary capillary leak
Am J Physiol Lung Cell Mol Physiol,
June 1, 2009;
296(6):
L1002 - L1011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Levitt, M. K. Gould, L. B. Ware, and M. A. Matthay
Analytic Review: The Pathogenetic and Prognostic Value of Biologic Markers in Acute Lung Injury
J Intensive Care Med,
May 1, 2009;
24(3):
151 - 167.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Elphick, P. P. Sarangi, Y.-M. Hyun, J. A. Hollenbaugh, A. Ayala, W. L. Biffl, H.-L. Chung, A. R. Rezaie, J. L. McGrath, D. J. Topham, et al.
Recombinant human activated protein C inhibits integrin-mediated neutrophil migration
Blood,
April 23, 2009;
113(17):
4078 - 4085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Russo, U. J. K. Soh, M. M. Paing, P. Arora, and J. Trejo
Caveolae are required for protease-selective signaling by protease-activated receptor-1
PNAS,
April 14, 2009;
106(15):
6393 - 6397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Russo, U. J. K. Soh, and J. Trejo
Proteases Display Biased Agonism at Protease-Activated Receptors: Location matters!
Mol. Interv.,
April 1, 2009;
9(2):
87 - 96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Niessen, C. Furlan-Freguia, J. A. Fernandez, L. O. Mosnier, F. J. Castellino, H. Weiler, H. Rosen, J. H. Griffin, and W. Ruf
Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality
Blood,
March 19, 2009;
113(12):
2859 - 2866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Perez-Casal, C. Downey, B. Cutillas-Moreno, M. Zuzel, K. Fukudome, and C. H. Toh
Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects
Haematologica,
March 1, 2009;
94(3):
387 - 394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gupta, B. Gerlitz, M. A. Richardson, C. Bull, D. T. Berg, S. Syed, E. J. Galbreath, B. A. Swanson, B. E. Jones, and B. W. Grinnell
Distinct Functions of Activated Protein C Differentially Attenuate Acute Kidney Injury
J. Am. Soc. Nephrol.,
February 1, 2009;
20(2):
267 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M R Looney, C T Esmon, and M A Matthay
Role of coagulation pathways and treatment with activated protein C in hyperoxic lung injury
Thorax,
February 1, 2009;
64(2):
114 - 120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. V. Yang, Y. Banerjee, J. A. Fernandez, H. Deguchi, X. Xu, L. O. Mosnier, Rolf. T. Urbanus, P. G. de Groot, T. C. White-Adams, O. J. T. McCarty, et al.
Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells
PNAS,
January 6, 2009;
106(1):
274 - 279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Uhlig and E. Gulbins
Sphingolipids in the Lungs
Am. J. Respir. Crit. Care Med.,
December 1, 2008;
178(11):
1100 - 1114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Thiyagarajan, J. A. Fernandez, S. M. Lane, J. H. Griffin, and B. V. Zlokovic
Activated Protein C Promotes Neovascularization and Neurogenesis in Postischemic Brain via Protease-Activated Receptor 1
J. Neurosci.,
November 26, 2008;
28(48):
12788 - 12797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bovill, I. D Bezemer, S. J Hasstedt, P. W Callas, R. P. Hebbel, and F. Rosendaal
IGSF4: A Novel Candidate Gene for Venous Thrombosis
Blood (ASH Annual Meeting Abstracts),
November 16, 2008;
112(11):
405 - 405.
[Abstract]
|
 |
|

|
 |

|
 |
 
R. Kamp, X. Sun, and J. G. N. Garcia
Making Genomics Functional: Deciphering the Genetics of Acute Lung Injury
Proceedings of the ATS,
April 15, 2008;
5(3):
348 - 353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Saposnik, E. Lesteven, A. Lokajczyk, C. T. Esmon, M. Aiach, and S. Gandrille
Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma
Blood,
April 1, 2008;
111(7):
3442 - 3451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schouten, W. J. Wiersinga, M. Levi, and T. van der Poll
Inflammation, endothelium, and coagulation in sepsis
J. Leukoc. Biol.,
March 1, 2008;
83(3):
536 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Troyanovsky, D. F. Alvarez, J. A. King, and K. L. Schaphorst
Thrombin enhances the barrier function of rat microvascular endothelium in a PAR-1-dependent manner
Am J Physiol Lung Cell Mol Physiol,
February 1, 2008;
294(2):
L266 - L275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Riewald and R. A. Schuepbach
Protective Signaling Pathways of Activated Protein C in Endothelial Cells
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2008;
28(1):
1 - 3.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. O'Brien, M. A. Richardson, S. F. Mehrbod, D. T. Berg, B. Gerlitz, A. Gupta, and B. W. Grinnell
Activated Protein C Decreases Tumor Necrosis Factor Related Apoptosis-Inducing Ligand by an EPCR- Independent Mechanism Involving Egr-1/Erk-1/2 Activation
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2007;
27(12):
2634 - 2641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Bae, L. Yang, C. Manithody, and A. R. Rezaie
The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells
Blood,
December 1, 2007;
110(12):
3909 - 3916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. A. Komarova, D. Mehta, and A. B. Malik
Dual Regulation of Endothelial Junctional Permeability
Sci. Signal.,
November 13, 2007;
2007(412):
re8 - re8.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Omori, Y. Shikata, K. Sarai, N. Watanabe, J. Wada, N. Goda, N. Kataoka, K. Shikata, and H. Makino
Edaravone mimics sphingosine-1-phosphate-induced endothelial barrier enhancement in human microvascular endothelial cells
Am J Physiol Cell Physiol,
November 1, 2007;
293(5):
C1523 - C1531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Itagaki, J. K. Yun, J. A. Hengst, A. Yatani, C. J. Hauser, Z. Spolarics, and E. A. Deitch
Sphingosine 1-Phosphate Has Dual Functions in the Regulation of Endothelial Cell Permeability and Ca2+ Metabolism
J. Pharmacol. Exp. Ther.,
October 1, 2007;
323(1):
186 - 191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Kerschen, J. A. Fernandez, B. C. Cooley, X. V. Yang, R. Sood, L. O. Mosnier, F. J. Castellino, N. Mackman, J. H. Griffin, and H. Weiler
Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C
J. Exp. Med.,
October 1, 2007;
204(10):
2439 - 2448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Singleton, L. Moreno-Vinasco, S. Sammani, S. L. Wanderling, J. Moss, and J. G. N. Garcia
Attenuation of Vascular Permeability by Methylnaltrexone: Role of mOP-R and S1P3 Transactivation
Am. J. Respir. Cell Mol. Biol.,
August 1, 2007;
37(2):
222 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gupta, G. J. Rhodes, D. T. Berg, B. Gerlitz, B. A. Molitoris, and B. W. Grinnell
Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2
Am J Physiol Renal Physiol,
July 1, 2007;
293(1):
F245 - F254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-S. Li, L. Wu, and J. A. Fernandez
The Endothelial Protein C Receptor in Vascular Smooth Muscle Cells For Good or Bad?
Circ. Res.,
May 25, 2007;
100(10):
e86 - e86.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. O. Mosnier, B. V. Zlokovic, and J. H. Griffin
The cytoprotective protein C pathway
Blood,
April 15, 2007;
109(8):
3161 - 3172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Bae, L. Yang, and A. R. Rezaie
Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells
PNAS,
February 20, 2007;
104(8):
2867 - 2872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Thiyagarajan, T. Cheng, and B. V. Zlokovic
Endothelial Cell Protein C Receptor: Role Beyond Endothelium?
Circ. Res.,
February 2, 2007;
100(2):
155 - 157.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Singleton, S. M. Dudek, S.-F. Ma, and J. G. N. Garcia
Transactivation of Sphingosine 1-Phosphate Receptors Is Essential for Vascular Barrier Regulation: NOVEL ROLE FOR HYALURONAN AND CD44 RECEPTOR FAMILY
J. Biol. Chem.,
November 10, 2006;
281(45):
34381 - 34393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Stephenson, L. J. Toltl, S. Beaudin, and P. C. Liaw
Modulation of Monocyte Function by Activated Protein C, a Natural Anticoagulant
J. Immunol.,
August 15, 2006;
177(4):
2115 - 2122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Feistritzer, R. A. Schuepbach, L. O. Mosnier, L. A. Bush, E. Di Cera, J. H. Griffin, and M. Riewald
Protective Signaling by Activated Protein C Is Mechanistically Linked to Protein C Activation on Endothelial Cells
J. Biol. Chem.,
July 21, 2006;
281(29):
20077 - 20084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-V. Nguyen, J.-L. Chen, J. Zhong, K.-J. Kim, E. D. Crandall, Z. Borok, Y. Chen, and D. K. Ann
SUMOylation Attenuates Sensitivity toward Hypoxia- or Desferroxamine-Induced Injury by Modulating Adaptive Responses in Salivary Epithelial Cells
Am. J. Pathol.,
May 1, 2006;
168(5):
1452 - 1463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Romer, K. G. Birukov, and J. G.N. Garcia
Focal Adhesions: Paradigm for a Signaling Nexus
Circ. Res.,
March 17, 2006;
98(5):
606 - 616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Feistritzer, B. A. Mosheimer, D. H. Sturn, M. Riewald, J. R. Patsch, and C. J. Wiedermann
Endothelial Protein C Receptor-Dependent Inhibition of Migration of Human Lymphocytes by Protein C Involves Epidermal Growth Factor Receptor
J. Immunol.,
January 15, 2006;
176(2):
1019 - 1025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Li, X. Zheng, J.-M. Gu, G. L. Ferrell, M. Brady, N. L. Esmon, and C. T. Esmon
Extraembryonic expression of EPCR is essential for embryonic viability
Blood,
October 15, 2005;
106(8):
2716 - 2722.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|